Novavax, Inc. (NVAX) Announces Exercise Of Option To Purchase Additional Shares And Closing Of Public Offering
6/12/2014 7:34:54 AM
GAITHERSBURG, Md., June 11, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the closing of the underwritten public offering priced on Thursday, June 5, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by